Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577966 · ClinicalTrials.gov registry record · NA
Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01577966: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT01577966 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01577966, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The main purpose of this part of the study is to determine the Central Nervous System bioavailability of sulfasalazine.
Primary Outcome
To determine the ability of sulfasalazine to alter glioma glutamate levels. These levels will be measured by Magnetic Resonance Spectroscopy (MRS). The percent change is noted per subject. The measure is a % decrease of glioma glutamate levels
Interventions
- DRUG Sulfasalazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT01577966 record still lists
NCT01577966 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Sulfasalazine is the first listed.
NCT01577966 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01577966 about?
NCT01577966 is a clinical study titled "Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma". The main purpose of this part of the study is to determine the Central Nervous System bioavailability of sulfasalazine.
What is the current status of trial NCT01577966?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01577966?
The interventions under investigation include: Sulfasalazine (DRUG).
Who is sponsoring clinical trial NCT01577966?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01577966's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia